TriSalus Life Sciences (TLSIW) Cash from Operations (2021 - 2026)
TriSalus Life Sciences posted quarterly Cash from Operations of 6480000.0 for Q1 2026, down 44.03% year-on-year from 11578046.07 in Q1 2025, and down 160.87% on a QoQ basis from 2484000.0 in Q4 2025.
TriSalus Life Sciences (TLSIW) has 6 years of Cash from Operations data on file, last reported at 6480000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 44.03% year-over-year to 6480000.0; the trailing twelve-month figure through Mar 2026 stood at 19993000.0 (up 42.01% YoY), and the FY2025 full-year result was 18012000.0, up 55.9% from the prior year.
- Cash from Operations for Q1 2026 stood at 6480000.0, down from 2484000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 425954.0 in Q1 2022 and bottomed at 22880298.0 in Q3 2022.
- The 5-year median for Cash from Operations is 8310000.0 (2022), against an average of 8719176.47.
- The widest annual swing landed in 2022, when Cash from Operations slumped 6166.19%; it then surged 65.81% in 2025.
- A 5-year view of Cash from Operations shows it stood at 8310000.0 in 2022, then decreased by 10.43% to 9177000.0 in 2023, then surged by 37.81% to 5707000.0 in 2024, then surged by 56.47% to 2484000.0 in 2025, then sank by 160.87% to 6480000.0 in 2026.
- The last three Cash from Operations figures came in at 6480000.0 (Q1 2026), 2484000.0 (Q4 2025), and 3709000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | -6.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.48 Mn |
| Mar 31, 2026 | -6.48 Mn |
| Dec 31, 2025 | -2.48 Mn |
| Dec 31, 2025 | -2.48 Mn |
| Sep 30, 2025 | -3.71 Mn |
| Sep 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -7.32 Mn |
| Jun 30, 2025 | -7.32 Mn |
| Mar 31, 2025 | -4.50 Mn |
| Mar 31, 2025 | -4.50 Mn |
| Dec 31, 2024 | -5.71 Mn |
| Dec 31, 2024 | -5.71 Mn |
| Sep 30, 2024 | -10.85 Mn |
| Sep 30, 2024 | -10.85 Mn |
| Jun 30, 2024 | -13.42 Mn |
| Jun 30, 2024 | -13.42 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | -9.18 Mn |
| Dec 31, 2023 | -9.18 Mn |
| Sep 30, 2023 | -21.66 Mn |
| Sep 30, 2023 | -21.66 Mn |
| Jun 30, 2023 | -9.24 Mn |
| Jun 30, 2023 | -9.24 Mn |
| Mar 31, 2023 | -10.50 Mn |
| Mar 31, 2023 | -10.50 Mn |
| Dec 31, 2022 | -8.31 Mn |
| Dec 31, 2022 | -8.31 Mn |
| Sep 30, 2022 | -22.88 Mn |
| Sep 30, 2022 | -22.88 Mn |
| Jun 30, 2022 | -696,748.00 |
| Jun 30, 2022 | -696,748.00 |
| Mar 31, 2022 | -425,954.00 |
| Mar 31, 2022 | -425,954.00 |
| Dec 31, 2021 | -680,921.00 |
| Dec 31, 2021 | -680,921.00 |
| Sep 30, 2021 | -365,139.00 |
| Sep 30, 2021 | -365,139.00 |
| Jun 30, 2021 | -486,206.00 |
| Jun 30, 2021 | -486,206.00 |
| Mar 31, 2021 | -205,848.00 |
| Mar 31, 2021 | -205,848.00 |